SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-22-025415
Filing Date
2022-11-18
Accepted
2022-11-18 09:15:22
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 sabs__424b3__q3_10-q.htm 424B3 2632210
2 EX-31.1 sabs-ex31_1.htm EX-31.1 31776
3 EX-31.2 sabs-ex31_2.htm EX-31.2 31779
4 EX-32.1 sabs-ex32_1.htm EX-32.1 13741
5 EX-32.2 sabs-ex32_2.htm EX-32.2 14207
6 GRAPHIC img231542136_0.jpg GRAPHIC 62859
  Complete submission text file 0000950170-22-025415.txt   2811199
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-261496 | Film No.: 221400705
SIC: 2836 Biological Products, (No Diagnostic Substances)